Economy

Best Hospitals for Thymus Cancer Worldwide

Published

2 years ago

27/04/2023

According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.

Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.

Criteria for selecting the best hospitals for thymus cancer

Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:

Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
Information about oncologists and thoracic surgeons who work in this hospital.
It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
It is advisable to choose several hospitals and compare them.
The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.

Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.

Top hospitals for thymus cancer treatment in the United States

University Hospitals Michigan Ann Arbor

Langone Hospital New York

Wisconsin University Hospitals Madison

Benefits of Medical Treatment in the US

Several essential advantages of the list of hospitals in the US:

Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
World-class thoracic surgeons who are proficient in all modern methods.

Top hospitals for thymus cancer treatment in Europe

University Hospital Frankfurt, Germany

Marien Hospital Marl, Germany

Teknon Medical Centre, Spain

Anadolu Medical Centre, Turkey

Benefits of medical treatment in Europe

European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:

World leadership in the number of scientific papers and discoveries in medicine.
Use of unique developments and author’s methods.
Careful monitoring of compliance with international standards at all stages of manipulation.

Top hospitals for thymus cancer treatment in Poland

Medicover Hospital Warsaw

European Health Center Otwock

Gamma Knife Exira Center Katowice

Benefits of medical treatment in Poland

Advantages of Polish cancer treatment:

Fast and accurate examination, low-traumatic technologies.
Complex treatment, including thymus surgery, chemo, and radiotherapy.
Remote consultations with doctors after completion of therapy.

Top hospitals for thymus cancer treatment in Italy

University Hospital San Raffaele Milan

European Oncology Institute Milan

Agostino Gemelli University Policlinic Rome

Benefits of medical treatment in Italy

A whole list of hospitals in Italy has such advantages:

The best doctors with extensive experience treating thymus tumors.
Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
Healthcare costs are more affordable than in America, and the quality is not inferior.

Top hospitals for thymus cancer treatment in Germany

Helios Clinic Berlin-Buch

University Hospital Charite

University Hospital Heidelberg

Benefits of medical treatment in Germany

Several advantages of hospitals in Germany:

Hybrid operating rooms, robot-assisted surgery.
Close cooperation of German thoracic surgeons with many narrow specialists.
Pediatric thoracic surgeons and oncologists are at the disposal of young patients.

Best thymus cancer doctors worldwide

The best doctors in thymus cancer treatment:

Prof. Dr. med. Maximilian Bockhorn

Dr. med. habil. Krzysztof Wrobel

Prof. Dr. Thomas Vogl

Prof. Dr. Hans Hoffmann

Prof. Dr. Helmut Friess

Best treatment solutions for treating thymus cancer

Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.

Here we will mention only a few:

Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.

How to get treatment in the best clinics for thymus cancer

Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.

The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:

Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
New therapy methods are used only in a few cancer centers.

Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.

References

Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/

Up Next

I’m Not Threatened by Otedola’s Investment in Transcorp—Elumelu

Don't Miss

NASD Securities Market Extends Loss by 0.03%

Dipo Olowookere

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via dipo.olowookere@businesspost.ng

1 Comment

Economy

Market Sheds 0.25% as Tantalizers Stocks, Others Shed Weight

Published

1 day ago

15/03/2025

Dipo Olowookere

By Dipo Olowookere

The Nigerian Exchange (NGX) Limited suffered a 0.25 per cent hair cut on Friday after investors offloaded some stocks, including Tantalizers, which topped the losers’ chart.

The company was the worst-performing equity during the session after it shed 9.85 per cent to settle at N2.93, Jaiz Bank lost 9.72 per cent to trade at N3.25, Neimeth declined by 9.45 per cent to N2.49, Dangote Sugar tumbled by 7.76 per cent to N35.05, and Lasaco Assurance shrank by 5.96 per cent to N2.68.

On the flip side, Royal Exchange gained 10.00 per cent to finish at 88 Kobo, Linkage Assurance soared by 9.57 per cent to N1.26, Guinea Insurance appreciated by 9.52 per cent to 69 Kobo, Enamelware inflated by 9.05 per cent to N25.30, and Red Star Express rose by 8.41 per cent to N5.80.

Business Post reports that the market breadth was negative on the last trading session of the week, with 24 depreciating shares and 22 appreciating share, showing a weak investor sentiment.

Apart from the insurance index, which closed higher by 0.12 per cent, and the commodity space, which closed flat, every other sector crumbled.

The consumer goods counter deflated by 1.08 per cent, the banking industry went down by 0.22 per cent, the energy sector fell by 0.18 per cent, and the industrial goods counter retreated by 0.03 per cent.

At the close of trades, the All-Share Index (ASI) decreased by 265.81 points to 105,955.13 points from 106,220.94 points and the market capitalisation dropped N166 billion to end at N66.352 trillion compared with Thursday’s value of N66.518 trillion.

A total of 750.6 million stocks worth N11.1 billion exchange hands in 10,584 deals during the session versus the 341.7 million stocks valued at N16.7 billion transacted in 11,233 deals a day earlier, implying a rise in the trading volume by 119.67 per cent, and a decline in the trading value and number of deals by 33.54 per cent and 5.78 per cent apiece.

Champion Breweries topped the activity chart with 350.4 million units worth N1.4 billion, Tantalizers sold 53.1 million units for N157.1 million, Custodian Investment traded 51.1 million units valued at N1.0 billion, Lasaco Assurance transacted 36.5 million units worth N97.7 million, and Access Holdings exchanged 30.7 million units valued at N723.0 million.

Economy

Unlisted Securities Bourse Down by 0.60%

Published

1 day ago

15/03/2025

Adedapo Adesanya

By Adedapo Adesanya

There was a 0.6 per cent decline at NASD Over-the-Counter (OTC) Securities Exchange on Friday, March 14, with the Unlisted Security Index (NSI) dropping 20.44 points to close at 3,363.74 points, in contrast to the previous trading day’s 3,384.18 points and the market capitalisation of the bourse losing N11.81 billion at session to settle at N1.942 trillion compared with the preceding day’s N1.954 trillion.

Yesterday, Okitipupa Plc went down by N30.00 to close at N300.00 per share compared with Thursday’s value of N330.00 per share, Central Securities Clearing System (CSCS) Plc shrank by 31 Kobo to trade at N21.69 per unit versus the previous day’s N22.00 per unit, and Geo Fluids slid by 31 Kobo to trade at N2.84 per share, in contrast the N3.15 per share it was traded a day earlier.

However, FrieslandCampina Wamco Nigeria Plc rose by N2.66 to N38.23 per unit from N35.57 per unit, Afriland Properties Plc expanded by 30 Kobo to N23.20 per share from its previous rate of N22.90 per share, and AG Mortgage Bank Plc increased by 5 Kobo to close at 53 Kobo per unit versus 48 Kobo per unit.

During the session, the volume of securities traded at the bourse fell by 72.6 per cent to 652,237 units from the 3.9 million units recorded on Thursday.

But the value of securities traded went up by 40.5 per cent to N33.1 million from the N23.6 million quoted at the preceding session and the number number of deals increased by 11.7 per cent to 37 deals from 17 deals.

Impresit Bakolori Plc was the most active stock by value (year-to-date) with 533.9 million units sold for N520.9 million, the second position was occupied by FrieslandCampina Wamco Nigeria Plc with 13.0 million units valued at N502.4 million, and the third spot was taken by Afriland Properties Plc with 17.4 million units worth N356.2 million.

The most active stock by volume (year-to-date) was also Impresit Bakolori Plc with 533.9 million units valued at N520.9 million, followed by Industrial and General Insurance (IGI) Plc with 69.9 million units sold for N23.7 million, and Afriland Properties Plc with 17.4 million units valued at N356.2 million.

Economy

Naira Appreciates to N1,522/$1 at Official Market on FX Liquidity Boost

Published

1 day ago

15/03/2025

Adedapo Adesanya

By Adedapo Adesanya

The Naira recorded its first gain against the United States Dollar in the Nigerian Autonomous Foreign Exchange Market (NAFEM) this week on Friday, March 14, firming up by 1.19 per cent or N18.31 to close at N1,522.37/$1 compared with the preceding day’s N1.540.68/$1.

This was supported by the injection of FX into the market by the Central Bank of Nigeria (CBN).

Over the last few sessions, the local currency had depreciate following recent pressures in the market as interventions have failed to ease pressure welling in the market with the country’s foreign reserves losing over $2 billion in the last month.

However, there were fresh injections at the session, which boosted the value of the local currency in the official market.

Equally, the domestic currency appreciated against the British Pound Sterling at NAFEM yesterday by N25.93 to sell at N1,640.20/£1 versus the previous day’s N1,990.13/£1 and improved its value against the Euro by N22.30 to quote at N1,653.78/€1, in contrast to the preceding session’s value of N1,676.08/€1.

In the parallel market, the value of the Nigerian Naira remained unchanged against the US Dollar during the trading day at N1,590/$1.

As for the cryptocurrency market, sellers of risk assets took a breather yesterday, with crypto markets posting sizable gains after risk appetite returned to markets.

Solana (SOL) jumped by 6.7 per cent to trade at $133.10, Ripple (XRP) gained 4.1 per cent to finish at $2.39, Cardano (ADA) went up by 3.8 per cent to settle at $0.7356, Dogecoin (DOGE) rose by 2.5 per cent to sell at $0.1723, Bitcoin (BTC) grew by 2.3 per cent to end at $83,987.28, Litecoin (LTC) added 3.0 per cent to quote at $91.48, Binance Coin (BNB) appreciated by 1.8 per cent to $590.92, and Ethereum (ETH) improved its value by 1.4 per cent to sell at $1,919.80, while the US Dollar Tether (USDT) and the US Dollar Coin (USDC) remained unchanged at $1.00 each.